These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11795687)

  • 1. A critical assessment of generic substitution for the obstetrician-gynecologist.
    Keith LG; Oleszczuk JJ; Ahranjani M
    Int J Fertil Womens Med; 2001; 46(6):286-95. PubMed ID: 11795687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Generic drug substitution].
    Tamir O; Halkin H; Shemer J
    Harefuah; 2006 Sep; 145(9):691-5, 701. PubMed ID: 17078434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Generics of antiepileptic drugs].
    Maeder-Ingvar M; Foletti GB
    Rev Med Suisse; 2010 May; 6(247):907-9. PubMed ID: 20499577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generics and substitution modalities: proposed methods for the evaluation of equivalence, traceability and pharmacovigilance reporting.
    Lamarque V; Merle L; Demarez JP;
    Therapie; 2008; 63(4):301-9. PubMed ID: 18937910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The generics in transplantation and the rules on their use.
    Masri M
    Exp Clin Transplant; 2003 Jun; 1(1):65-8. PubMed ID: 15859910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Generics: essentially similar, bioequivalent but not identical].
    Even-Adin D; De Muylder JA; Sternon J
    Rev Med Brux; 2001 Dec; 22(6):513-20. PubMed ID: 11811047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Debate: Substitution of generic drugs in epilepsy: is there cause for concern?
    Gidal BE; Tomson T
    Epilepsia; 2008 Dec; 49 Suppl 9():56-62. PubMed ID: 19087118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Generic drugs, alternatives, substitutes, interchanges].
    Kolár J; Chalabala M
    Ceska Slov Farm; 1999 Mar; 48(2):59-64. PubMed ID: 10376417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendations of the Italian League against Epilepsy working group on generic products of antiepileptic drugs.
    Perucca E; Albani F; Capovilla G; Bernardina BD; Michelucci R; Zaccara G
    Epilepsia; 2006; 47 Suppl 5():16-20. PubMed ID: 17239100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.
    Duh MS; Cahill KE; Paradis PE; Cremieux PY; Greenberg PE
    Expert Opin Pharmacother; 2009 Oct; 10(14):2317-28. PubMed ID: 19663636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generic drugs in reproductive medicine: is the value anticipated the value obtained?
    Keith LG; Method MW
    Int J Fertil; 1987; 32(4):268-78. PubMed ID: 2887523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generics market in Greece: the pharmaceutical industry's beliefs.
    Geitona M; Zavras D; Hatzikou M; Kyriopoulos J
    Health Policy; 2006 Nov; 79(1):35-48. PubMed ID: 16386326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Generic substitution of depot preparations containing opioids. Cost savings with great expenses?].
    Christrup LL; Jensen NH; Jonsson T; Kristensen HG; Sjøgren P; Steffansen B
    Ugeskr Laeger; 2009 May; 171(19):1624; author reply 1624. PubMed ID: 19425257
    [No Abstract]   [Full Text] [Related]  

  • 14. Generic substitution of itraconazole resulting in sub-therapeutic levels and resistance.
    Pasqualotto AC; Denning DW
    Int J Antimicrob Agents; 2007 Jul; 30(1):93-4. PubMed ID: 17412566
    [No Abstract]   [Full Text] [Related]  

  • 15. Differentiating low-molecular-weight heparins based on chemical, biological, and pharmacologic properties: implications for the development of generic versions of low-molecular-weight heparins.
    Jeske WP; Walenga JM; Hoppensteadt DA; Vandenberg C; Brubaker A; Adiguzel C; Bakhos M; Fareed J
    Semin Thromb Hemost; 2008 Feb; 34(1):74-85. PubMed ID: 18393144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical and economic impact of generic drugs in the treatment of epilepsy].
    Argumosa A; Herranz JL
    Rev Neurol; 2005 Jul 1-15; 41(1):45-9. PubMed ID: 15999330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures.
    Berg MJ; Gross RA; Tomaszewski KJ; Zingaro WM; Haskins LS
    Neurology; 2008 Aug; 71(7):525-30. PubMed ID: 18695164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Generics: authorization to market and quality guarantees].
    De Muylder JA
    Rev Med Brux; 2000 Sep; 21(4):A276-8. PubMed ID: 11068480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effectiveness of generic agents in psychopharmacologic treatment.
    Kumet R; Gelenberg AJ
    Essent Psychopharmacol; 2005; 6(2):104-11. PubMed ID: 15765794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of generic competition on the price of brand-name drugs.
    Lexchin J
    Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.